| Sequential ventilation/perfusion imaging of massive pulmonary embolism treated with recombinant tissue plasminogen activator. | |
| | |
MedLine Citation:
|
PMID: 2107996 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Pulmonary embolism is a common clinical problem estimated to cause 200,000 deaths per year in the United State. There is increasing interest in early diagnosis and prompt aggressive therapy. A case is reported of a patient with massive pulmonary embolism treated with recombinant tissue plasminogen activator. Ventilation/perfusion imaging was used both to make an early diagnosis as well as to evaluate the efficacy of therapy. |
| | |
Authors:
|
J Petronis |
Related Documents
:
|
14966076 - Massive pulmonary haemorrhage complicating the treatment of acute coronary syndrome. 6621846 - Fatal complication of the "bonnet bypass": case report. 3651276 - Massive intraoperative pulmonary embolism in a child. 7444046 - Control of massive hemoptysis by embolization of intercostal arteries. 8926196 - Aortic and iliac artery thrombosis in calves: nine cases (1974-1993). 6509906 - Carnitine ester hydrolysis in arteries from normal and cholesterol-fed rabbits and the ... |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Clinical nuclear medicine Volume: 15 ISSN: 0363-9762 ISO Abbreviation: Clin Nucl Med Publication Date: 1990 Mar |
Date Detail:
|
Created Date: 1990-05-09 Completed Date: 1990-05-09 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 7611109 Medline TA: Clin Nucl Med Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 150-3 Citation Subset: IM |
Affiliation:
|
Division of Nuclear Medicine, Francis Scott Key Medical Center, Baltimore, Maryland 21224. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Humans Lung / radionuclide imaging* Male Pulmonary Embolism / drug therapy, radionuclide imaging* Recombinant Proteins / therapeutic use Tissue Plasminogen Activator / therapeutic use* Ventilation-Perfusion Ratio* |
| Chemical | |
Reg. No./Substance:
|
0/Recombinant Proteins; EC 3.4.21.68/Tissue Plasminogen Activator |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: CO2 laser cauterization of giant-cell tumor margins.
Next Document: Ifosfamide and mesna.